OncoVista Innovative Therapies, Inc.
OVIT
$0.0001
-$0.0001-50.00%
OTC PK
09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 61.30K | 28.10K | 56.00K | 12.50K | 75.60K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | 43.60K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 61.30K | 28.10K | 56.00K | 12.50K | 119.20K |
|
|||||
Total Current Assets | 61.30K | 28.10K | 56.00K | 12.50K | 119.20K |
Net Property, Plant & Equipment | -- | -- | -- | 0.00 | 0.00 |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 61.30K | 28.10K | 56.00K | 12.50K | 119.20K |
|
|||||
Total Accounts Payable | 765.00K | 680.80K | 1.75M | 1.67M | 1.41M |
Total Accrued Expenses | 3.06M | 2.90M | 2.78M | 2.65M | 2.43M |
Short-term Debt | 479.30K | 410.60K | 323.00K | 208.30K | 204.30K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.65M | 2.37M | 450.00K | 450.00K | 159.10K |
Total Other Current Liabilities | 1.65M | 2.37M | 450.00K | 450.00K | 159.10K |
Total Current Liabilities | 5.95M | 6.36M | 5.30M | 4.98M | 4.21M |
|
|||||
Total Current Liabilities | 5.95M | 6.36M | 5.30M | 4.98M | 4.21M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 479.30K | 410.60K | 323.00K | 208.30K | 204.30K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 700.00K | 700.00K | 700.00K | 700.00K | -- |
Total Liabilities | 6.65M | 7.06M | 6.00M | 5.68M | 4.21M |
|
|||||
Common Stock & APIC | 21.01M | 20.24M | 20.24M | 20.24M | 20.24M |
Retained Earnings | -27.60M | -27.28M | -26.18M | -25.90M | -24.33M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -6.59M | -7.04M | -5.94M | -5.66M | -4.09M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -6.59M | -7.04M | -5.94M | -5.66M | -4.09M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -6.59M | -7.04M | -5.94M | -5.66M | -4.09M |
|